For Research Use Only. Not for use in diagnostic procedures.
The AVENIO ctDNA Surveillance Kit is a next-generation sequencing (NGS) liquid biopsy research assay that’s specially designed and optimized for longitudinal tumor burden monitoring in lung cancer and colorectal cancer (CRC) research. The Surveillance panel contains 197 genes, including those in U.S. National Comprehensive Cancer Network (NCCN) Guidelines.1
The AVENIO ctDNA Surveillance Kit V2 is one of three assays in the AVENIO ctDNA research assay portfolio. Learn more about the 17-gene AVENIO ctDNA Targeted Kit V2 for guideline-driven tumor profiling or the 77-gene AVENIO ctDNA Expanded Kit V2 for profiling emerging and guideline-driven biomarkers.